Employee Benefits Updates provided by Parker, Smith & Feek

What You Should Know About Biosimilars

Rapidly increasing healthcare costs will likely continue to impact employers in the foreseeable future. As a result, many employers are considering strategies to manage healthcare costs and explore prescription drug trends. The introduction of biosimilar drugs as an alternative to biologics may bring value to healthcare by offering cost savings and increasing employee access to necessary medications. While biosimilars can potentially combat rising prescription drug costs, employers will need to learn more about them before considering how their health plans can accommodate these newer drugs.

To learn more, read the most recent HR Insight

The views and opinions expressed within are those of the author(s) and do not necessarily reflect the official policy or position of Parker, Smith & Feek. While every effort has been taken in compiling this information to ensure that its contents are totally accurate, neither the publisher nor the author can accept liability for any inaccuracies or changed circumstances of any information herein or for the consequences of any reliance placed upon it.

Parker, Smith & Feek is and independent, employee owned, full service insurance broker offering employee benefits, commercial and personal insurance, and surety solutions. Our Employee Benefits Department has been helping clients create and administer valuable benefits programs since 1975.

Visit Parker, Smith & Feek's website to learn more about our services.

PRIVACY POLICY DISCLAIMER